Search results
Should You Buy Agree Realty Stock While It's Below $65? | The Motley Fool
The Motley Fool· 4 days agoIn 2022 Agree Realty's (ADC 0.46%) stock price rose to around $80 a share. If you are an income...
3 No-Brainer Dividend Stocks to Buy Right Now for Less Than $1,000
Motley Fool via Yahoo Finance· 7 days agoREITs tend to be great dividend growth stocks. Agree Realty (NYSE: ADC), Rexford Industrial Realty...
Grand Canyon pit stop is now a bona fide hot spot
CNN via Yahoo News· 1 day agoIn addition to tours, exhibits, stargazing and a chance to peer through historic telescopes, the observatory that discovered Pluto in 1930 is opening the...
Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever
Motley Fool via Yahoo Finance· 2 days agoScotiabank hails from Canada, but, unlike most large Canadian banks, it chose to skip over the...
The Smartest Dividend Stocks to Buy With $500 Right Now
Motley Fool via Yahoo Finance· 3 days agoAct now while you still can Even if you only have $500 to invest you'll want to consider putting...
Innovent Reports Oncology Pipeline Updates at Investor Meeting
Morningstar· 6 days agoSAN FRANCISCO and SUZHOU, China, June 18, 2024 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes ...
RME Babyface Pro FS
Mountain View Telegraph· 7 days agoRME's distinguished do-it-all desktop interface just got even better. The Babyface Pro came along five years later and Mark Wherry echoed Sam's sentiment...
5 Biotech Stocks With Key Catalysts This Week: Merck, Intellia, Verona, And More - SPDR Series Trust...
Benzinga· 23 hours agoBiotech stocks are high-risk, high-return opportunities that are under the mercy of several...
Zentalis' shares plunge 30% after FDA places WEE1 drug on partial hold over sepsis deaths
FierceBiotech· 7 days agoThe FDA has placed three trials of Zentalis’ WEE1 candidate on partial hold in the wake of two...
Multidrug Regimen Could Change Treatment Landscape for Relapsed/Refractory DLBCL
MedPage Today· 6 days agoHigh-rate of durable responses with ViPOR sparks talk of supplanting CAR-T in second line